Literature DB >> 7554401

Defective expression of early activation genes in cartilage-hair hypoplasia (CHH) with severe combined immunodeficiency (SCID).

E Castigli1, A M Irani, R S Geha, T Chatila.   

Abstract

Cartilage-hair hypoplasia (CHH) is an autosomal recessive disease of unknown etiology characterized by metaphyseal dysostosis, unpigmented hair, and defective cellular immunity. We studied peripheral blood mononuclear cells (PBMC) of a boy with CHH and combined immunodeficiency in an attempt to characterize further the immune defect in this disease. Stimulation of his PBMC with mitogens was associated with severely depressed IL-2 and interferon-gamma (IFN-gamma) synthesis and IL-2 receptor alpha-chain (IL-2R alpha) expression and resulted in poor lymphocyte proliferation that was only modestly upregulated by the addition of recombinant IL-2 (rIL-2). The defective proliferation and lymphokine synthesis were not corrected by the addition of phorbol myristate acetate (PMA) and ionomycin, agents that bypass receptor-mediated signalling, indicative of a distal abnormality. Importantly, the levels of mRNA encoding c-myc, IL-2R alpha, IL-2 and IFN-gamma were markedly decreased in patient lymphocytes stimulated with PMA+ionomycin as compared to control lymphocytes. The defect in the expression of these early activation genes was selective in that induction by mitogens of mRNA encoding other early activation gene products such as c-fos and c-jun was not impaired. These results suggest that the underlying defect in this patient and perhaps others with CHH may be an abnormality in a component of intracellular signalling pathways or in a trans-acting factor which regulates the expression of a selected number of early activation genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554401      PMCID: PMC1553351          DOI: 10.1111/j.1365-2249.1995.tb06628.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

Authors:  K Kelly; B H Cochran; C D Stiles; P Leder
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

2.  Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.

Authors:  J C Reed; J D Alpers; P C Nowell; R G Hoover
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 3.  Cartilage hair hypoplasia: immunological aspects and their clinical implications.

Authors:  S H Polmar; G F Pierce
Journal:  Clin Immunol Immunopathol       Date:  1986-07

4.  Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes.

Authors:  J W Lowenthal; D W Ballard; E Böhnlein; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.

Authors:  S L Cross; N F Halden; M J Lenardo; W J Leonard
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

6.  Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression.

Authors:  B Hoyos; D W Ballard; E Böhnlein; M Siekevitz; W C Greene
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

7.  HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor.

Authors:  K Leung; G J Nabel
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

8.  Lymphocyte dysfunction in cartilage-hair hypoplasia: evidence for an intrinsic defect in cellular proliferation.

Authors:  G F Pierce; S H Polmar
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes.

Authors:  E Serfling; R Barthelmäs; I Pfeuffer; B Schenk; S Zarius; R Swoboda; F Mercurio; M Karin
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  5 in total

1.  Cartilage-hair hypoplasia syndrome: increased apoptosis of T lymphocytes is associated with altered expression of Fas (CD95), FasL (CD95L), IAP, Bax, and Bcl2.

Authors:  L Yel; S Aggarwal; S Gupta
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

2.  Novel Mutation and Structural RNA Analysis of the Noncoding RNase MRP Gene in Cartilage-Hair Hypoplasia.

Authors:  Imane Cherkaoui Jaouad; Fatima Z Laarabi; Siham Chafai Elalaoui; Stanislas Lyonnet; Alexandra Henrion-Caude; Abdelaziz Sefiani
Journal:  Mol Syndromol       Date:  2015-06-11

3.  Reduced thymic output, cell cycle abnormalities, and increased apoptosis of T lymphocytes in patients with cartilage-hair hypoplasia.

Authors:  Miguel A de la Fuente; Mike Recher; Nicholas L Rider; Kevin A Strauss; D Holmes Morton; Margaret Adair; Francisco A Bonilla; Hans D Ochs; Erwin W Gelfand; Itai M Pessach; Jolan E Walter; Alejandra King; Silvia Giliani; Sung-Yun Pai; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2011-05-13       Impact factor: 10.793

4.  Small RNAs derived from lncRNA RNase MRP have gene-silencing activity relevant to human cartilage-hair hypoplasia.

Authors:  Leslie E Rogler; Brian Kosmyna; David Moskowitz; Remon Bebawee; Joseph Rahimzadeh; Katrina Kutchko; Alain Laederach; Luigi D Notarangelo; Silvia Giliani; Eric Bouhassira; Paul Frenette; Jayanta Roy-Chowdhury; Charles E Rogler
Journal:  Hum Mol Genet       Date:  2013-09-05       Impact factor: 6.150

5.  Cartilage hair hypoplasia: characteristics and orthopaedic manifestations.

Authors:  Patrick Riley; Dennis S Weiner; Bonnie Leighley; David Jonah; D Holmes Morton; Kevin A Strauss; Michael B Bober; Martin S Dicintio
Journal:  J Child Orthop       Date:  2015-03-13       Impact factor: 1.548

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.